Ascendis Pharma A/S announced positive results from Week 214 of its Phase 2 PaTH Forward Trial, indicating that long-term treatment with TransCon PTH (palopegteriparatide) effectively maintains a ...

LabVantage Pharma is the only pre-configured and pre-validated pharmaceutical LIMS in the world. This greatly lowers the deployment cost (85%) and time (75%) compared to a traditional LIMS ...

Ascendis Pharma COPENHAGEN, Denmark, May 13, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new data showing improvements in growth and bone morphometry from Week 52 ...

Ascendis Pharma COPENHAGEN, Denmark, May 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new data from Week 214 of its Phase 2 PaTH Forward Trial showing that long ...

COPENHAGEN, Denmark, May 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new data from Week 214 of its Phase 2 PaTH Forward Trial showing that long-term treatment with ...

(Reuters) -French drugmaker Sanofi said on Wednesday it plans to invest at least $20 billion in the United States through ...

COPENHAGEN, Denmark, May 13, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new data showing improvements in growth and bone morphometry from Week 52 of its pivotal ...

"It validates our technology platform amid the growing demand for comprehensive intelligence solutions in the pharmaceutical and biotech sectors, reaffirming our commitment to innovation and ...

2023 Memphis Pharmaceutical & Chemical Industries 0.67 6.46 EGP 2022 Memphis Pharmaceutical & Chemical Industries 0.00 0.00 EGP 2021 Memphis Pharmaceutical & Chemical Industries 0.00 0.00 EGP 2019 ...

Visit a quote page and your recently viewed tickers will be displayed here.

Visit a quote page and your recently viewed tickers will be displayed here.